drugset / Trial / NCT06380205

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

NCT06380205

Phase 1 Completed 24 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the drug interaction between povorcitinib and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

Timeline

Start
2024-05-07
Primary completion
2024-06-07
Completion
2024-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule
Subject Povorcitinib Small molecule
Subject ethinyl estradiol Small molecule

Indications

No indication recorded.